NPH16
Product Specifications
Target
PD-1/PD-L1
Related Pathways
Apoptosis, Cell Cycle/Checkpoint, Immunology/Inflammation
Bioactivity
NPH16 is an orally active PD-1/PD-L1 inhibitor with an IC50 of 2.24 nM. It promotes apoptosis in HepG2 cells and demonstrates outstanding antitumor efficacy and favorable pharmacokinetic properties in vivo. NPH16 is applicable for liver cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2904094-01 48 Well
Dog PDE6B/Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta ELISA Kit
Sign In for Pricing
View Details MBS2904094-02 96 Well
Dog PDE6B/Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta ELISA Kit
Sign In for Pricing
View Details MBS2904094-03 5x 96 Well
Dog PDE6B/Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta ELISA Kit
Sign In for Pricing
View Details MBS2904094-04 10x 96 Well
Dog PDE6B/Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta ELISA Kit
Sign In for Pricing
View Details 
